ETR:COP

CompuGroup Medical SE & Co. KGaA Stock Forecast, Price & News

€68.30
+0.40 (+0.59 %)
(As of 06/17/2021 12:00 AM ET)
Add
Compare
Today's Range
€66.80
€68.55
50-Day Range
€62.50
€76.30
52-Week Range
€59.40
€85.40
Volume80,922 shs
Average Volume68,245 shs
Market Capitalization$3.63 billion
P/E Ratio51.47
Dividend Yield0.74%
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive COP News and Ratings via Email

Sign-up to receive the latest news and ratings for CompuGroup Medical SE & Co. KGaA and its competitors with MarketBeat's FREE daily newsletter.


CompuGroup Medical SE & Co. KGaA logo

About CompuGroup Medical SE & Co. KGaA

CompuGroup Medical SE & Co. KGaA develops and sells software and information technology solutions for the healthcare sector worldwide. It operates in four segments: Ambulatory Information Systems (AIS), Pharmacy Information Systems (PCS), Hospital Information Systems (HIS), and Consumer & Health Management Information Systems (CHS). The AIS segment provides practice management software and electronic medical records for registered physicians, medical care centers, and physicians networks, as well as offers supplementary Internet and intranet solutions. The PCS segment provides administrative and billing-related software applications for pharmacies. Its software solution provides information and decision support to manage various aspects of supply chain for medication. The HIS segment provides clinical and administrative solutions for the inpatient sector. This segment serves acute care hospitals, rehabilitation centers, social services, multi-location hospital networks and regional care organizations, and medical laboratories. The CHS segment provides IT security services, data-based product offers, software interface for sharing of information, clinical decision-making support, and medication and treatment databases for healthcare service providers, as well as digital healthcare stock, consumer portals, and mobile apps. This segment also offers security solutions for healthcare providers. It serves pharmaceutical companies, health insurance companies, and other healthcare IT companies and consumers. The company was formerly known as CompuGroup Medical SE and changed its name to CompuGroup Medical SE & Co. KGaA in June 2020. CompuGroup Medical SE & Co. KGaA was founded in 1987 and is headquartered in Koblenz, Germany.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

1.45 out of 5 stars

Analyst Opinion: 3.2Community Rank: 2.6Dividend Strength: 0.8Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











CompuGroup Medical SE & Co. KGaA (ETR:COP) Frequently Asked Questions

Is CompuGroup Medical SE & Co. KGaA a buy right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for CompuGroup Medical SE & Co. KGaA in the last twelve months. There are currently 1 sell rating, 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CompuGroup Medical SE & Co. KGaA stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in COP, but not buy additional shares or sell existing shares.
View analyst ratings for CompuGroup Medical SE & Co. KGaA
or view top-rated stocks.

What stocks does MarketBeat like better than CompuGroup Medical SE & Co. KGaA?

Wall Street analysts have given CompuGroup Medical SE & Co. KGaA a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but CompuGroup Medical SE & Co. KGaA wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is CompuGroup Medical SE & Co. KGaA's next earnings date?

CompuGroup Medical SE & Co. KGaA is scheduled to release its next quarterly earnings announcement on Thursday, August 5th 2021.
View our earnings forecast for CompuGroup Medical SE & Co. KGaA
.

How has CompuGroup Medical SE & Co. KGaA's stock been impacted by COVID-19 (Coronavirus)?

CompuGroup Medical SE & Co. KGaA's stock was trading at €55.20 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, COP shares have increased by 23.7% and is now trading at €68.30.
View which stocks have been most impacted by COVID-19
.

Is CompuGroup Medical SE & Co. KGaA a good dividend stock?

CompuGroup Medical SE & Co. KGaA pays an annual dividend of €0.50 per share and currently has a dividend yield of 0.74%. The dividend payout ratio of CompuGroup Medical SE & Co. KGaA is 37.68%. This payout ratio is at a healthy, sustainable level, below 75%.
View CompuGroup Medical SE & Co. KGaA's dividend history.

What price target have analysts set for COP?

5 brokers have issued twelve-month price objectives for CompuGroup Medical SE & Co. KGaA's shares. Their forecasts range from €65.00 to €88.00. On average, they expect CompuGroup Medical SE & Co. KGaA's stock price to reach €80.00 in the next year. This suggests a possible upside of 17.1% from the stock's current price.
View analysts' price targets for CompuGroup Medical SE & Co. KGaA
or view top-rated stocks among Wall Street analysts.

Who are CompuGroup Medical SE & Co. KGaA's key executives?

CompuGroup Medical SE & Co. KGaA's management team includes the following people:
  • Mr. Michael Rauch, CFO & Member of Management Board (Age 49, Pay $1.24M)
  • Mr. Hannes Reichl, MD of Impatient & Social Care and Member of the Management Board (Age 45, Pay $766.28k)
  • Mr. Frank Brecher, CTO, MD & Member of Management Board (Age 52, Pay $608.62k)
  • Dr. Ralph Körfgen Ph.D., MD of Ambulatory & Pharmacy Information Systems and Member of Management Board (Age 55, Pay $739.2k)
  • Dr. Eckart Pech, MD of Consumer & Health Management Information Systems and Member of the Management Board (Age 52, Pay $772.5k)
  • Dr. Dirk Wossner, MD, CEO & Chairman of Management Board (Age 52)
  • Ms. Claudia Thomé, Head of Investor Relations (Age 51)
  • Mr. Oliver Bruzek, Chief Communication Officer of Political & Public Affairs
  • Michael Franz, Head of Brand Communication
  • Mr. Helge Weiß, Sr. VP of Connectivity

Who are some of CompuGroup Medical SE & Co. KGaA's key competitors?

What other stocks do shareholders of CompuGroup Medical SE & Co. KGaA own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CompuGroup Medical SE & Co. KGaA investors own include Netflix (NFLX), Whiting Petroleum (WLL), NovelStem International (HOLL), (KOG) (KOG), Vaccinex (VCNX), Whiting USA Trust II (WHZT), Microchip Technology (MCHP), NVIDIA (NVDA), Axon Enterprise (AAXN) and Applegreen (APGN).

What is CompuGroup Medical SE & Co. KGaA's stock symbol?

CompuGroup Medical SE & Co. KGaA trades on the ETR under the ticker symbol "COP."

What is CompuGroup Medical SE & Co. KGaA's stock price today?

One share of COP stock can currently be purchased for approximately €68.30.

How much money does CompuGroup Medical SE & Co. KGaA make?

CompuGroup Medical SE & Co. KGaA has a market capitalization of $3.63 billion and generates $914.86 million in revenue each year.

How many employees does CompuGroup Medical SE & Co. KGaA have?

CompuGroup Medical SE & Co. KGaA employs 7,534 workers across the globe.

What is CompuGroup Medical SE & Co. KGaA's official website?

The official website for CompuGroup Medical SE & Co. KGaA is www.cgm.com.

Where are CompuGroup Medical SE & Co. KGaA's headquarters?

CompuGroup Medical SE & Co. KGaA is headquartered at Maria Trost 21, KOBLENZ, 56070, Germany.

How can I contact CompuGroup Medical SE & Co. KGaA?

CompuGroup Medical SE & Co. KGaA's mailing address is Maria Trost 21, KOBLENZ, 56070, Germany. The company can be reached via phone at +49-261-80000.


This page was last updated on 6/18/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.